Press coverage about Kewaunee Scientific (NASDAQ:KEQU) has trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Kewaunee Scientific earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave press coverage about the technology company an impact score of 46.1903539080085 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Shares of Kewaunee Scientific (KEQU) traded down $0.80 during trading hours on Tuesday, hitting $25.50. The stock had a trading volume of 9,400 shares, compared to its average volume of 2,130. Kewaunee Scientific has a 12 month low of $20.95 and a 12 month high of $31.20. The company has a market capitalization of $71.55, a PE ratio of 15.27 and a beta of 0.05. The company has a current ratio of 2.12, a quick ratio of 1.58 and a debt-to-equity ratio of 0.04.

Kewaunee Scientific (NASDAQ:KEQU) last issued its quarterly earnings data on Tuesday, December 5th. The technology company reported $0.62 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 10.61% and a net margin of 3.28%. The company had revenue of $41.47 million during the quarter.

In related news, Director Donald F. Shaw purchased 888 shares of the business’s stock in a transaction that occurred on Tuesday, December 26th. The stock was acquired at an average cost of $28.78 per share, for a total transaction of $25,556.64. Following the completion of the purchase, the director now owns 21,250 shares in the company, valued at approximately $611,575. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Donald F. Shaw purchased 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 27th. The stock was bought at an average price of $28.79 per share, with a total value of $57,580.00. The disclosure for this purchase can be found here. Insiders own 20.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://theolympiareport.com/2018/02/13/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-kewaunee-scientific-kequ-share-price.html.

About Kewaunee Scientific

Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.

Insider Buying and Selling by Quarter for Kewaunee Scientific (NASDAQ:KEQU)

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.